Sligo - Ireland
€66,548 to €72,514 or £57,883.18 to £63,072.39 (converted salary*)
2026-05-01
2026-05-28
Description of Post
SensABLATE is a flagship collaborative research initiative funded under the Disruptive Technologies Innovation Fund (DTIF), bringing together academic, clinical, and industry partners to develop next-generation precision imaging technologies for lung cancer therapy. The project aims to deliver a transformative intraoperative decision-support platform by integrating advanced optical imaging with artificial intelligence to enable real-time tissue viability assessment and therapy guidance. Through SensABLATE, ATU will advance translational biophotonics and intelligent imaging platforms toward clinical deployment, strengthening Ireland’s position in next-generation medical device innovation.
The successful candidate will develop AI-driven computational models for multimodal optical imaging data analysis and real-time tissue viability mapping and work as part of a research team.
Essential Qualifications